Publications by authors named "Milton Pifano Soares Ferreira"
Correction to: Real‑world imatinib mesylate treatment in patients with chronic myeloid leukemia: The importance of molecular monitoring and the early molecular response.
Amanda Pifano Soares Ferreira Fernanda Salles Seguro Andre Ramires Neder Abdo Fernanda Maria Santos Felipe Vieira Rodrigues Maciel Milton Pifano Soares Ferreira
Ann Hematol
July 2023
Real-world Imatinib Mesylate Treatment in Patients with Chronic Myeloid Leukemia: The Importance of Molecular Monitoring and the Early Molecular Response.
Amanda Pifano Soares Ferreira Fernanda Salles Seguro Andre Ramires Neder Abdo Fernanda Maria Santos Felipe Vieira Rodrigues Maciel Milton Pifano Soares Ferreira
Ann Hematol
July 2023
Introduction: Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder characterized by the Philadelphia (Ph) chromosome. After the introduction of imatinib mesylate (IM) in 2000, the natural history of the disease changed. Data on the treatment of CML with IM are from randomized clinical trials.
View Article and Find Full Text PDF